an increased fibrinolytic activity leading to an acquired plasminogen defect is seen 1 ) in situations complicated with a free proteolytic activity most often involving both the fibrinolytic and the coagulation systems , 2 ) as a result of locally increased fibrinolytic activity ( angiomas ) , 3 ) during thrombolytic therapy using plasminogen activators ( sk , uk , tpa ) .
C0032144
plasminogen activators
C0032143
tpa